Prognostic Significance of Blood, Serum, and Ascites Parameters in Patients with Malignant Peritoneal Mesothelioma or Peritoneal Carcinomatosis

Table 3

Survival time and potential prognostic factors in patients with mesothelioma and peritoneal carcinomatosis.

Prognostic factors	Mesothelioma ()	Peritoneal carcinomatosis ()	value
Median survival time (months)	11	7.5	0.034
Sex (M/F)	16/27	33/49	0.741
Age (years)	60.7 ± 8.5	61.6 ± 12.7	0.660
Ascites glucose level (mmol/L)	4.83 ± 2.05	5.74 ± 1.96	0.015
Ascites albumin level (g/L)	28.02 ± 3.94	25.3 ± 7.21	0.046
Ascites LDH level, median (U/L)	323	252	0.293
Ascites monocyte numbers, median (%)	70	70	0.800
Ascites coenocyte numbers, median (%)	30	30	0.800
Ascites coenocyte-to-monocyte ratio	0.43	0.43	0.800
Serum albumin level (g/L)	34.14 ± 5.16	35.18 ± 5.13	0.274
Serum-ascites albumin gradient (g/L)	6.74 ± 3.32	10.06 ± 4.18	0.002
Serum LDH level, median (U/L)	191	248	0.046
Ascites-serum LDH ratio, median	2.00	1.05	0.004
Blood neutrophil-to-lymphocyte ratio, median	3.35	4.00	0.034